Lexeo Therapeutics Inc (LXEO) Stock Price, Quote, News & History

LXEONASDAQ
$4.16
0.030.73%
At close: Sep 15, 5:00 PM EST
$4.16
0.030.73%
Pre-Market: 4:00 AM EST

Lexeo Therapeutics (LXEO) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-88.37M
Investing Cash Flow (TTM)
-24.95M
Financing Cash Flow (TTM)
170.68M
Free Cash Flow (TTM)
-88.70M
Capital Expenditure (TTM)
-331.00K
Net Change in Cash (TTM)
57.35M

Analyst Trends and Forecast

1
May
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$136.42M
PE Ratio (TTM)
-
PE Ratio (FWD)
7.50
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.45
Earnings Yield % (TTM)
-21.15%
Earnings Yield % (FWD)
13.34%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.87

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$515.00K
Total Cash
$92.83M
Debt to Equity
0.03
Issuance of Debt (TTM)
-$515.00K
Repayment of Debt (TTM)
-$515.00K

Key Statistics

Open
-
Close
$4.16
Volume / Avg.
0 / 911.99K
Day Range
- - -
52 Wk Range
3.99 - 10.99
Market Cap
$341.31M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
36
Short Interest
29.13%
Days to Cover
26.82

About

Sector
Health Care
Industry
Biotechnology
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Lexeo Therapeutics (LXEO) stock?

A

You can purchase shares of Lexeo Therapeutics (NASDAQ:LXEO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lexeo Therapeutics (LXEO) competitors?

Q

What is the forecast, or price target, for Lexeo Therapeutics (LXEO) stock?

A

Lexeo Therapeutics has a consensus price target of $19.42.

Q

What is the current price for Lexeo Therapeutics (LXEO)?

A

The stock price for Lexeo Therapeutics (NASDAQ: LXEO) is $4.16 last updated September 16, 2026 at 4:00 PM EDT.

Q

Does Lexeo Therapeutics (LXEO) pay a dividend?

A

There are no upcoming dividends for Lexeo Therapeutics.

Q

When is Lexeo Therapeutics (NASDAQ:LXEO) reporting earnings?

A

Lexeo Therapeutics does not have any upcoming earnings scheduled.

Q

Is Lexeo Therapeutics (LXEO) going to split?

A

There is no upcoming split for Lexeo Therapeutics.

Q

What sector and industry does Lexeo Therapeutics (LXEO) operate in?

A

Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.